Literature DB >> 7767528

Hyperoxic lung injury reduces exogenous surfactant clearance in vivo.

W E Novotny1, B B Hudak, S Matalon, B A Holm.   

Abstract

We studied the rate of clearance of treatment doses of radiolabeled calf lung surfactant extract, which was instilled into the lungs of young adult rabbits exposed to air (control) or 100% oxygen for 64 h. More than 75% of the instilled surfactant remained lung-associated at all time points up to 24 h post-instillation in both groups; however, significantly more of the labeled phosphatidylcholine (PC) remained in the alveolar wash of oxygen-exposed rabbits (44 +/- 9% in 100% O2 versus 27 +/- 5% in controls at 6 h and 27 +/- 2% in 100% O2 versus 6 +/- 1% in control rabbits at 24 h, p < 0.05). Less of the labeled PC could be found in type II pneumocytes isolated from the oxygen exposed animals than in control animals, both at 6 h (24 +/- 2 cpm/10(6) cells in O2 versus 38 +/- 7 cpm/10(6) cells in control) and 24 h (42 +/- 5 cpm/10(6) cells in O2 versus 70 +/- 12 cpm/10(6) cells in control) post-instillation. Type II cells from animals exposed to 100% oxygen also demonstrated significantly lower PC synthesis rates than cells from lungs of control animals. Interestingly, clearance of exogenous surfactant in rabbits exposed to 100% oxygen for 48 h, an exposure that does not cause significant type II pneumocyte dysfunction, was not different from control. We concluded that injury to type II pneumocytes may result in decreased clearance of instilled surfactant from the alveolar space and may be important in determining dosing regimens for the use of surfactant therapy in adult respiratory distress syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7767528     DOI: 10.1164/ajrccm.151.6.7767528

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

Review 1.  Calfactant: a review of its use in neonatal respiratory distress syndrome.

Authors:  S V Onrust; M Dooley; K L Goa
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

Review 2.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

Review 3.  Protection of epithelial cells by keratinocyte growth factor signaling.

Authors:  Prabir Ray
Journal:  Proc Am Thorac Soc       Date:  2005

Review 4.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 5.  Surfactant for pediatric acute lung injury.

Authors:  Douglas F Willson; Patricia R Chess; Robert H Notter
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

6.  Spatial and temporal expression of surfactant proteins in hyperoxia-induced neonatal rat lung injury.

Authors:  Simone A J ter Horst; Margot Fijlstra; Sujata Sengupta; Frans J Walther; Gerry T M Wagenaar
Journal:  BMC Pulm Med       Date:  2006-04-18       Impact factor: 3.317

Review 7.  Pediatric Acute Respiratory Distress Syndrome: Fibrosis versus Repair.

Authors:  Daniel Im; Wei Shi; Barbara Driscoll
Journal:  Front Pediatr       Date:  2016-03-30       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.